Article Details

Avacta Announces License Agreement With POINT Biopharma Inc.

Retrieved on: 2021-01-07 07:07:30

Tags for this article:

Click the tags to see associated articles and topics

Avacta Announces License Agreement With POINT Biopharma Inc.. View article details on hiswai:

Excerpt

POINT Biopharma is a clinical-stage pharmaceutical company focused on developing radioligands2 as precision medicines for the treatment of cancer.

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up